Trials / Completed
CompletedNCT03625700
Supplementary Oxygen in Surgical and Medical Wards Evaluated by 30-day Mortality
Supplementary Oxygen in Surgical and Medical Wards in the Capital Region of Denmark Evaluated by 30-day Mortality, a Retrospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 11,196 (actual)
- Sponsor
- Hannibal Troensegaard · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the use and effects of supplementary oxygen in surgical and medical wards on patients admitted to a hospital in the capital region of Denmark. The population will be divided in to three groups according to their oxygenation status. The main outcome will be 30-day mortality, with secondary outcomes being Length of stay, 30-day admission to ICU, 30-day reoperations, 30-day readmission, and peak values within 30-days of C-reactive protein, S-Creatinine, Troponin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxygen gas | Supplementary oxygen supplied via nasal catheter or oxygen mask during hospital admission. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2020-08-01
- Completion
- 2020-12-01
- First posted
- 2018-08-10
- Last updated
- 2021-01-12
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03625700. Inclusion in this directory is not an endorsement.